Agios Pharmaceuticals Earning Date (AGIO)

USA |NASDAQ |USD

AGIO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jul 27, 2022 Jun 2022 - $-1.74 $-1.39
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jul 27, 2022 Jun 2022 - $832.00 $0.00

Agios Pharmaceuticals's next earnings date is Wednesday, Jul 27, 2022 for the fiscal quarter ending Jun 2022.

AGIO Earnings Date & History Chart

AGIO Earnings & Revenue Forecast

AGIO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 10 $-7.21 $-9.71 $-1.48

AGIO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-7.21 $-6.78 $-6.43

AGIO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 10 $54.97M $3.40M $276.34M

AGIO Earnings Date & Revenue History

AGIO Earnings History

|
Show More
Show More

AGIO Revenue History

|
Show More
Show More

Agios Pharmaceuticals Next Earnings Date & Report

AGIO Next Earnings Date & Report Preview: Jun 2022 (FQ)

AGIO's next earnings date is Wednesday, Jul 27, 2022 for the fiscal quarter ending Jun 30, 2022.

Agios Pharmaceuticals Previous Earnings Dates & Reports

AGIO Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Agios Pharmaceuticals's previous earnings date was May 5, 2022 for its fiscal quarter ended Mar 31, 2022.

AGIO's earnings per share (EPS) was $-1.74, beating the consensus analysts forecast of $-1.81 by 3.87%.

The EPS was higher than the previous fiscal quarter (Dec 2021) by 0.00%, and lower than the same period a year before (Mar 2021) by 32.82%.

Revenues were $832.00, up by 1909.18% from the previous quarter , and up by 1909.18% from the same period last year.

The company reported a net income of $-94.77K.

Free cash flow for the quarter was $-100.54M , compared to $4.64M last quarter and $-121.76M a year before.

AGIO ended the quarter with $94.61M in total debt, a decrease of -51.06% compared to the previous quarter, and a decrease of -8.69% compared to the same quarter a year before.

AGIO Previous Earnings Date & Report Recap: Dec 2021 (FY)

Agios Pharmaceuticals's previous annual earnings date was Feb 24, 2022 for its fiscal year ended Dec 31, 2021.

AGIO's earnings per share (EPS) was $-5.95, missing the consensus analysts forecast of $26.01 by -122.87% , and lower than the previous year's EPS (Dec 2020) by 25.50%.

Revenues were $41.41K, worse than the forecast of $4.74M by -99.13%, and down by -99.98% from previous year's revenue.

The company reported a net income of $1.60B.

Agios Pharmaceuticals reported a free cash flow of $-319.83M for its fiscal year, compared to $-305.67M a year ago.

The company ended the fiscal year with $193.31M in total debt, an increase of 83.75% compared to the previous year.